Navigation Links
2009 Medical Innovation Summit at Cleveland Clinic to Highlight the Latest Developments in Cancer Care
Date:6/24/2009

CLEVELAND, June 24 /PRNewswire/ -- Cancer therapies and diagnostics, including new technologies, enhanced biotech and drug developments, and the consumer market for genetic testing, will be at the center of Cleveland Clinic's 7th Annual Medical Innovation Summit, Oct. 5-7.

The Summit will bring together more than 900 leaders from throughout the healthcare industry to learn about the latest innovations in cancer care, exchange perspectives and gain actionable insights.

This year's Summit will highlight new technologies in the oncology field, giving attendees access to the latest innovations in cancer therapy, diagnostics and management. Drawing international CEOs, leading venture capitalists, entrepreneurs, renowned physicians and top technologists, the summit will examine in detail the hottest new cancer technologies, prospects for new cancer innovation, and forces shaping the markets for new cancer technology.

"This Medical Innovation Summit will bring together some of the most important thought leaders in the world of healthcare, cancer technology and venture investment. In light of the current economy, it is more important than ever to discuss the future of innovation and our increased need to support new technology," said Christopher Coburn, Executive Director of Cleveland Clinic Innovations. "Everyone has been touched in some way by cancer, and we are excited to highlight the many clinical innovations taking place in this field."

The 2009 Medical Innovation Summit will feature more than 40 international leaders, including CEOs Sam Palmisano, IBM; Daniel Vasella, M.D., Novartis; David Brennan, AstraZeneca; Richard Clark, Merck; Fred Hassan, Schering-Plough; Greg Lucier, Life Technology, FDA Commissioner Margaret Hamburg, M.D.; network correspondent Maria Bartiromo, CNBC; and the CEOs and venture investors of numerous emerging technology companies. For a complete list of spea
'/>"/>

SOURCE Cleveland Clinic
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Environmental Tectonics Corporations BioMedical Division to Exhibit at Undersea and Hyperbaric Medical Society Meeting
2. B. Braun Medical Inc. Recognized by Industry for Manufacturing Influential Medical Devices
3. Environmental Tectonics Corporations BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan
4. Greenway Medical Technologies To Display Live Interoperability Implementations at 2009 DIA Show
5. Campbell Alliance Launches New Practice Area Focused on Medical Affairs
6. Ten Top Latin American Scientists Named 2009 Pew Fellows in the Biomedical Sciences
7. Senator Arlen Specter and Richard Gephardt Headline Policy Forum on U.S. Medical Innovation, Highlight Achieving Recovery Through Discovery
8. Hill-Rom Innovative Envision(R) E700 Wound Surface Receives Gold Medical Device Excellence Award
9. NCIIA Honors Top Collegiate Biomedical Engineering Teams
10. Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
11. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)WALTHAM, Mass., Dec. 3 Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and h
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
(Date:12/2/2009)TUSTIN, Calif., Dec. 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today reported completion of patient enrollment in a dose confirmation and dosimetry trial of Cotara® in patients with rel
(Date:12/2/2009)JERUSALEM, Israel, December 2 Gamida Cell announced today,a feasibility study evaluating the preclinical (animal study) safety and,efficacy of a gene therapy product which combines technology from We
Breaking Biology Technology:Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 2Gamida Cell Announces Feasibility Study With Weill Cornell Medical College 3
...O, Sept. 29 Cadence Pharmaceuticals,Inc. (Nasdaq:...n-licensing,developing and commercializing proprie... hospital setting, announced today that the compan...ent the company,s corporate,overview on Monday, Oc...me),during the JMP Securities Third Annual Healthc...
...ology Medicaid Fraud Case; Qui Tam Whistleblower A...nt With Client,s Off-Label Marketing, Allegations ...llion Civil Settlement, $50 Million Corpor...Biotech drug manufacturer,Cephalon, Inc. ("Cephalo...or years by off-label marketing its first three pr...
..., Fla., Sept. 29 CPC of America, Inc.,(OTC Bullet...ained FTI,Capital Advisors, LLC, the investment ba...e strategic alternatives for the Company., As CPC...ors will report,to the Board any expressions of in...ible licensing agreement or acquisition of the Com...
Other Biology Technology:Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the JMP Securities Third Annual Healthcare Focus Conference 2$425 Million Cephalon Civil Settlement and Criminal Fine; In America's Largest 2$425 Million Cephalon Civil Settlement and Criminal Fine; In America's Largest 3CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities 2
(Date:12/3/2009)...h researchers have measured CO2 levels for the pas...) over a sparsely inhabited rural area near Vallad...nd in the Iberian Peninsula, show that the levels ...r recent years, physicists and meteorologists have...) levels, and how these have evolved in the tropos...
(Date:12/2/2009)...ELPHIA Children exposed to secondhand cigarette s...cer in adulthood, even if they never smoked. , R...emiology, Biomarkers & Prevention , a journal of t...rt of a special tobacco focus in the December issu...s will be diagnosed with lung cancer; more than 15...
(Date:12/2/2009)...ELPHIA People who smoke their first cigarette wit...s of cotinine, a by-product of nicotine when proce...gardless of the number of cigarettes smoked. , ... of lung cancer, our results suggest that smokers ...ly at risk for lung cancer," said researcher Joshu...
Breaking Biology News(10 mins):CO2 levels rising in troposphere over rural areas 2Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Increased nicotine levels detected in those who light-up earlier 2Local farmers in Africa to benefit from school meal programs 59518 1Local farmers in Africa to benefit from school meal programs 59518 2Local farmers in Africa to benefit from school meal programs 59518 3 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 1 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 2 244 million NCI grant funds comparative effectiveness research at Southwest Oncology Group 59516 3New mathematical model more accurately diagnoses acute heart failure in emergency rooms 59514 1New mathematical model more accurately diagnoses acute heart failure in emergency rooms 59514 2
...ue, Czech Republic A new clinical trial suggests ...y used to treat hypertension, may significantly re...elated report by Penicka et al, "The effects of ca...tion in non-obstructive hypertrophic cardiomyopath...ary issue of The Journal of Molecular Diagnostics...
...ing at structures only atoms across, researchers h...l virus nanomotor. , Because of the motor,s stren...w findings could inspire engineers designing sophi...er of virus types may possess a similar motor, inc...ay also assist pharmaceutical companies developing...
... NEW YORK (DECEMBER 26, 2008) A team of ...vation Society (WCS) has reported a rapid recovery...he tsunami that devastated coastal regions through... The WCS team, working in conjunction with ...ce for Coral Reef Studies (ARCCoERS) along with go...
Other Biology News:Viruses, start your engines! 2Viruses, start your engines! 34 years after tsunami: Corals stage comeback 24 years after tsunami: Corals stage comeback 3
...The CopyControl™ vector can be induced prior t...ctors provide the stability of single-copy BACs wi...r cloning vectors. The kits provide the linearized..., insert size screening system) necessary to creat...
Cell Wall Degrading Enzyme Complex Aspergillus sp. from Sigma-Aldrich
...Templates rich in GC content or with significant s...lify, and when subjected to PCR result in little o...an be increased by the addition of enhancing agent...an effective PCR enhancer for GC-rich templates.,...
...Application: The simple three step procedure (PCR,...sformation) can be completed in one day. The typic... than 80%. , Features and Benefits: , , Universal ...ector , High Cloning Efficiency - Typically>80% , ...
Biology Products: